A new study published in Cancer Medicine indicates that exosomes, or small bubbles that transport molecules from one cell to another, can be effective vehicles for delivering cancer treatments to tumors.
In the study, researchers used exosomes produced by cells called adipose-derived mesenchymal stem cells (ADSCs) to deliver an RNA-based anti-cancer treatment (miR-138-5p) to bladder cancer tumors in mice.
"The present results reveal that ADSC-derived exosomes are an effective delivery vehicle for small molecule drugs in vivo, and exosome-delivered miR-138-5p is a promising therapeutic agent for bladder cancer treatment," the authors wrote.
Cancer Medicine is pleased to announce its new Editor-in-Chief, Dr. Stephen Tait of the University of Glasgow, UK, and Co-Editors, Dr. Alfred Lam of Griffith University, Australia and Dr. Maryam Lustberg of Yale University, USA. With this change, the journal is also happy to announce the appointment of several new Associate Editors.
URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1002/cam4.4745
Additional Information
